Tag: The Braff Group
M&A activity in HME, home infusion heats up
September 3, 2026HME News Staff
PITTSBURGH – The home medical equipment (HME) industry is seeing a significant uptick in mergers and acquisitions (M&A) activity in 2026, based on annualized first half data collected and analyzed by The Braff Group.
There were 22 deals for 2025 and 36 deals for 2026, a 63.6% increase, with potential to reach their highest numbers since 2022, according to the firm’s “Mid-Year 2026 Update: The Rebound Continues.”
“When deal flow plunged from 2021 to 2023, you could...
In brief: M&A heats up, Aeroflow lands Fallon, Collins taps Medline
September 2, 2026HME News Staff
PITTSBURGH – The home medical equipment (HME) industry is seeing a significant uptick in mergers and acquisitions (M&A) activity in 2026, based on annualized first half data collected and analyzed by The Braff Group.
There were 22 deals for 2025 and 36 deals for 2026, a 63.6% increase, with potential to reach their highest numbers since 2022, according to the firm’s “Mid-Year 2026 Update: The Rebound Continues.”
“When deal flow plunged from 2021 to 2023, you could...
Moratorium complicates DME deals, but buyers stay engaged
April 17, 2026Theresa Flaherty
YARMOUTH, Maine – Medicare’s six-month moratorium on new DME supplier enrollments, which went into effect in late February, has not dampened deal-making activity, but that could change, say industry analysts.
The moratorium prevents:
Existing providers from opening new locations with new Medicare PTANs, effectively halting expansion efforts for many; and
Changes in majority ownership within 36 months of initial enrollment or a previous change in ownership.
“I've...
Dexter Braff on drop-offs, retreats and turnarounds
December 15, 2023Theresa Flaherty
YARMOUTH, Maine – When it comes to mergers and acquisitions, the HME industry has seen its share of ups and downs, says Dexter Braff, founder and president of The Braff Group, which recently celebrated 25 years.
These days, the biggest difference he sees is the amount of due diligence required to close a deal.
“In the past, once you signed a letter of intent, the percentage of deals that would not close would be in the 10% to 20% range,” said Braff. “Today,...
In brief: AdaptHealth’s Q3, Medela’s spin-off, Braff Group’s milestone
November 8, 2023HME News Staff
PLYMOUTH MEETING, Pa. – AdaptHealth reported net revenue of $804 million for the third quarter of 2023, an increase of 6.3% over the same quarter one year ago.
Net loss was $454.1 million compared to net income of $16.1 million, largely resulting from a $511.9 million pre-tax write down of goodwill.
Adjusted EBITDA was $161.2 million, compared to $160.2 million, an increase of 0.6%.
“We are pleased with the results of the third quarter,” said Richard Barasch,...
The Braff Group hits milestone
November 7, 2023HME News Staff
PITTSBURGH – The Braff Group has celebrated its 25th anniversary, marking 375 transactions in health care. The firm was founded with a simple goal in mind, it says – to amass a body of sector-specific health mergers and acquisitions experience, resources and data to give clients an edge in realizing the best deal at the best time. "We are extremely grateful to all the companies that put their faith in us to represent them and get the most from what, for many, was a lifetime of hard work,...
Amedysis exec joins The Braff Group
August 2, 2023HME News Staff
PITTSBURGH – Kris Novak has joined The Braff Group as a managing director of home health, home care and hospice, where he will be responsible for the western United States, joining Mark Kulik, senior managing director of home health, home are and hospice, Eastern United States. Novak has 14 years of M&A experience in the home health industry, most recently at Amedisys, where he most recently served as senior vice president of mergers, acquisitions and integration. While at Amedisys, Novak led...
M&A analysts: ‘Focus on acquiring solid companies’
February 10, 2023Theresa Flaherty
YARMOUTH, Maine – Industry analysts see steady deal-making in 2023, with a variety of companies making buys in both typically hot markets like respiratory and newly hot markets like repairs, but with more of a focus on due diligence.
“I think the interest is at both the national level, as well as the larger regionals, aggressively pursuing acquisitions,” said Pat Clifford, managing director, home medical equipment, for The Braff Group. “There is acquisition appetite...
Home infusion: Interest still high, inventory still low
March 4, 2022Theresa Flaherty
YARMOUTH, Maine – A handful of recently announced deals underscores the continued appetite for home infusion companies propelled by the COVID-19 pandemic, say M&A analysts.
Option Care Health recently announced it acquired Wasatch Infusion and entered into an agreement to acquire Specialty Pharmacy Nursing Network.
“Option Care has been doing deals for 20 years and I don’t think that’s going to stop – they continue to fill out their geographic...
OM’s Byram and Apria ‘complete each other’
January 28, 2022Theresa Flaherty
YARMOUTH, Maine – Owens & Minor’s anticipated acquisition of Apria Healthcare, announced earlier this month, follows the playbook of a deal generating synergies between buyer and “buyee,” but the companies have their work cut out for them, says Dexter Braff, president of the Braff Group.
“You’ve got two mammoth organization trying to find a way to work with one another to optimize these and leverage those opportunities,” he said. “It’s...